within Pharmacolibrary.Drugs.C_CardiovascularSystem.C05A_AgentsForTreatmentOfHemorrhoidsAndAnalFissuresForTopicalUse.C05AE03_Diltiazem;

model Diltiazem
  extends Pharmacolibrary.Drugs.ATC.C.C05AE03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C05AE03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Diltiazem is a calcium channel blocker used primarily for the treatment of hypertension, angina pectoris, and certain types of arrhythmias. It is an approved and widely used medication today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after single oral immediate-release dose.</p><h4>References</h4><ol><li><p>Kinney, EL, et al., &amp; Zelis, R (1981). The pharmacokinetics and pharmacology of oral diltiazem in normal volunteers. <i>Journal of clinical pharmacology</i> 21(8-9) 337–342. DOI:<a href=\"https://doi.org/10.1002/j.1552-4604.1981.tb01778.x\">10.1002/j.1552-4604.1981.tb01778.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7276227/\">https://pubmed.ncbi.nlm.nih.gov/7276227</a></p></li><li><p>Murata, K, et al., &amp; Samejima, M (1989). Pharmacokinetics of an oral sustained-release diltiazem preparation. <i>Journal of pharmaceutical sciences</i> 78(11) 960–963. DOI:<a href=\"https://doi.org/10.1002/jps.2600781116\">10.1002/jps.2600781116</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2621582/\">https://pubmed.ncbi.nlm.nih.gov/2621582</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Diltiazem;
